Deep venous thrombosis in pregnancy: Incidence, pathogenesis and endovascular management

Paola Devis, M. Grace Knuttinen

Research output: Contribution to journalReview articlepeer-review

29 Scopus citations


Deep venous thrombosis (DVT) during pregnancy is associated with high mortality, morbidity, and costs. Pulmonary embolism (PE), its most feared complication, is the leading cause of maternal death in the developed world. DVT can also result in long-term complications that include postthrombotic syndrome (PTS) adding to its morbidity. Women are up to 5 times more likely to develop DVT when pregnant. The current standard of care for this condition is anticoagulation. This review discusses the epidemiology, pathogenesis, prophylaxis and diagnosis of DVT during pregnancy, and then focuses on endovascular treatment modalities. Inferior vena cava (IVC) filter placement and pharmacomechanical catheter directed thrombolysis (PCDT) in the pregnant patient are discussed, as well as patient selection criteria, and complications.

Original languageEnglish (US)
Pages (from-to)S300-S319
JournalCardiovascular Diagnosis and Therapy
StatePublished - Dec 1 2017


  • Deep vein thrombosis
  • Risk factor
  • Unfractionated heparin (UFH)

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Deep venous thrombosis in pregnancy: Incidence, pathogenesis and endovascular management'. Together they form a unique fingerprint.

Cite this